With the highly infectious Delta variant becoming dominant in South Africa, the health department says there is no data yet to assess the efficacy of the Johnson & Johnson vaccine against it.
Read more here:: ZA Local News
With the highly infectious Delta variant becoming dominant in South Africa, the health department says there is no data yet to assess the efficacy of the Johnson & Johnson vaccine against it.
Read more here:: ZA Local News